republic-os/legislation/us/states/va/2020/hb-860.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Inhaled asthma medications; school nurse, etc., may administer to a student.	Professional use by practitioners; administration of albuterol inhalers or nebulized albuterol. Provides that, pursuant to an order or standing protocol issued by the prescriber within the course of his professional practice, any school nurse, school board employee, employee of a local governing body, employee of a local health department, employee of a school for students with disabilities, or employee of an accredited private school who is authorized by a prescriber and trained in the administration of albuterol inhalers or nebulized albuterol may possess or administer an albuterol inhaler or nebulized albuterol to a student diagnosed with a condition requiring an albuterol inhaler or nebulized albuterol when the student is believed to be experiencing or about to experience an asthmatic crisis. The bill also provides that a school nurse, employee of a school board, employee of a local governing body, or employee of a local health department who is authorized by a prescriber and trained in the administration of albuterol inhalers or nebulized albuterol who provides, administers, or assists in the administration of an albuterol inhaler or nebulized albuterol for a student believed in good faith to be in need of such medication, or is the prescriber of such medication, is not liable for civil damages for ordinary negligence in acts or omissions resulting from the rendering of such treatment. This bill is identical to HB 1174.	us/states/va	Virginia General Assembly	2020	HB 860	Virginia HB 860 (2020)	bill		enacted	Robert B. Bell	5	38	7	2020-01-07	2020-03-25	openstates	ocd-bill/5d76ec37-0b69-4f95-a80f-13f420f68586	https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+HB860	5ff09f5d33dbb1257797988bb2ac964f9a1b50a25c9b7f2e3942b95d8e7ca099	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-va

Virginia HB 860 (2020) — Inhaled asthma medications; school nurse, etc., may administer to a student.

Professional use by practitioners; administration of albuterol inhalers or nebulized albuterol. Provides that, pursuant to an order or standing protocol issued by the prescriber within the course of his professional practice, any school nurse, school board employee, employee of a local governing body, employee of a local health department, employee of a school for students with disabilities, or employee of an accredited private school who is authorized by a prescriber and trained in the administration of albuterol inhalers or nebulized albuterol may possess or administer an albuterol inhaler or nebulized albuterol to a student diagnosed with a condition requiring an albuterol inhaler or nebulized albuterol when the student is believed to be experiencing or about to experience an asthmatic crisis. The bill also provides that a school nurse, employee of a school board, employee of a local governing body, or employee of a local health department who is authorized by a prescriber and trained in the administration of albuterol inhalers or nebulized albuterol who provides, administers, or assists in the administration of an albuterol inhaler or nebulized albuterol for a student believed in good faith to be in need of such medication, or is the prescriber of such medication, is not liable for civil damages for ordinary negligence in acts or omissions resulting from the rendering of such treatment. This bill is identical to HB 1174.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Acts of Assembly Chapter text (CHAP0459) (committee substitute) — source
2. Bill text as passed House and Senate (HB860ER) (committee substitute) — source
3. Engrossed by House - committee substitute HB860H1 (committee substitute) — source
4. Impact statement from DPB (HB860) (committee substitute) — source
5. Impact statement from DPB (HB860S1) (committee substitute) — source

Votes

• Passed Senate with substitute (40-Y 0-N) — 40–0 (pass) · upper
• Subcommittee recommends reporting with substitute (6-Y 0-N) — 6–0 (pass) · lower
• VOTE: Adoption (97-Y 0-N) — 96–0 (pass) · lower
• Constitutional reading dispensed (32-Y 0-N) — 32–0 (pass) · upper
• VOTE: (99-Y 0-N) — 98–0 (pass) · lower
• Reported from Health, Welfare and Institutions with substitute (22-Y 0-N) — 22–0 (pass) · lower
• Reported from Education and Health with substitute (15-Y 0-N) — 15–0 (pass) · upper

Sponsors

• Robert B. Bell — primary (person)
• Mark L. Keam — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2020-01-07 Prefiled and ordered printed; offered 01/08/20 20104680D introduction
• 2020-01-07 Referred to Committee on Health, Welfare and Institutions referral-committee
• 2020-01-15 Assigned HWI sub: Health Professions referral-committee
• 2020-01-15 Impact statement from DPB (HB860)
• 2020-01-16 House committee, floor amendments and substitutes offered
• 2020-01-16 Subcommittee recommends reporting with substitute (6-Y 0-N)
• 2020-01-21 House committee, floor amendments and substitutes offered
• 2020-01-21 Reported from Health, Welfare and Institutions with substitute (22-Y 0-N) committee-passage
• 2020-01-21 Committee substitute printed 20105551D-H1 substitution
• 2020-01-23 Read first time reading-1
• 2020-01-24 Read second time reading-2
• 2020-01-24 Committee substitute agreed to 20105551D-H1
• 2020-01-24 Engrossed by House - committee substitute HB860H1
• 2020-01-27 Read third time and passed House BLOCK VOTE (99-Y 0-N) passage, reading-3
• 2020-01-27 VOTE: (99-Y 0-N)
• 2020-01-28 Impact statement from DPB (HB860H1)
• 2020-01-28 Constitutional reading dispensed
• 2020-01-28 Referred to Committee on Education and Health referral-committee
• 2020-02-12 Assigned Education sub: Health Professions referral-committee
• 2020-02-20 Reported from Education and Health with substitute (15-Y 0-N) committee-passage
• 2020-02-20 Committee substitute printed 20108267D-S1 substitution
• 2020-02-21 Constitutional reading dispensed (32-Y 0-N)
• 2020-02-21 Impact statement from DPB (HB860S1)
• 2020-02-24 Read third time reading-3
• 2020-02-24 Reading of substitute waived
• 2020-02-24 Committee substitute agreed to 20108267D-S1
• 2020-02-24 Engrossed by Senate - committee substitute HB860S1
• 2020-02-24 Passed Senate with substitute (40-Y 0-N) passage
• 2020-02-26 Placed on Calendar
• 2020-02-26 Senate substitute agreed to by House 20108267D-S1 (97-Y 0-N)
• 2020-02-26 VOTE: Adoption (97-Y 0-N)
• 2020-03-02 Enrolled
• 2020-03-02 Impact statement from DPB (HB860ER)
• 2020-03-02 Signed by Speaker
• 2020-03-03 Signed by President
• 2020-03-12 Enrolled Bill communicated to Governor on March 12, 2020
• 2020-03-12 Governor's Action Deadline 11:59 p.m., April 11, 2020
• 2020-03-25 Approved by Governor-Chapter 459 (effective 7/1/20) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/5d76ec37-0b69-4f95-a80f-13f420f68586. Confidence: reported (aggregated from official Virginia legislature records).